Table 2 Baseline demographics, treatment, and follow-up characteristics of patients with B-cell neoplasms included in a shared care follow-up initiative
Characteristic | Total |
|---|---|
N | 80 |
Female | 38 |
Male | 42 |
Age, y; median | 68 |
Age range, y | 28–82 |
Diagnosis | |
FL | 29 |
DLBCL | 14 |
CLL | 17 |
MZL | 10 |
WM | 5 |
LPL | 3 |
MCL | 1 |
HL | 1 |
Number of visits to a physician, median (range) | 1 (0–4) |
Number of nurse consultations, median (range) | 1 (0–4) |
Time since diagnosis, y; median (range) | 4.4 (1.1–20.2) |
Time since last treatment, y; median (range) | 3.4 (1.3–16.3) |
Follow-up interval, months | |
2–3 | 34 |
4–5 | 25 |
6 | 21 |
Number of treatment lines | |
1 | 48 |
2 | 4 |
> 2 | 4 |
No previous treatment (watch and wait) | 24 |